Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Covid Medicines Delivery Unit (CMDU) Service to Somerset Integrated Care Board

  • First published: 12 March 2025
  • Last modified: 12 March 2025
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
ocds-h6vhtk-04ded0
Published by:
NHS Somerset Integrated Care Board
Authority ID:
AA83542
Publication date:
12 March 2025
Deadline date:
17 March 2025
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The service will assess all patients in the community aged 18 years and over who are identified as being at high risk of an adverse outcome from Covid and have Covid symptoms and/or a positive lateral flow test. It is expected that these patients will have been provided with a letter by NHSE or have been identified as high risk by their specialist/consultant.

The service will assess the patient and where appropriate prescribe Covid medications. Where the patient does not fit the criteria for oral medication but may be eligible for second line intravenous medication, the service will make a referral to Somerset NHS Foundation Trust (Somerset FT) via Somerset Primary Link (SPL) for consideration and treatment if appropriate.

The contract term will be for 2 years with an optional extension of any period up to 1 year.

The contract value is £110,000.00 per annum giving a contract value of £220,000.00 for the initial contract period and £330,000.00 if the full extension period is adopted.

The new service will commence on the 1st October 2025

This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

NHS Somerset Integrated Care Board

11X

Wynford House

Yeovil

BA22 8HR

UK

Contact person: Ian Weston

Telephone: +44 2380627444

E-mail: Ian.Weston3@nhs.net

NUTS: UKK23

Internet address(es)

Main address: https://health-family.force.com/s/Welcome

Address of the buyer profile: www.nhssomerset.nhs.uk

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://atamis-1928.my.site.com/s/Welcome


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://atamis-1928.my.site.com/s/Welcome


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Covid Medicines Delivery Unit (CMDU) Service to Somerset Integrated Care Board

Reference number: C338990-W160439

II.1.2) Main CPV code

85100000

 

II.1.3) Type of contract

Services

II.1.4) Short description

The service will assess all patients in the community aged 18 years and over who are identified as being at high risk of an adverse outcome from Covid and have Covid symptoms and/or a positive lateral flow test. It is expected that these patients will have been provided with a letter by NHSE or have been identified as high risk by their specialist/consultant.

The service will assess the patient and where appropriate prescribe Covid medications. Where the patient does not fit the criteria for oral medication but may be eligible for second line intravenous medication, the service will make a referral to Somerset NHS Foundation Trust (Somerset FT) via Somerset Primary Link (SPL) for consideration and treatment if appropriate.

The contract term will be for 2 years with an optional extension of any period up to 1 year.

The contract value is £110,000.00 per annum giving a contract value of £220,000.00 for the initial contract period and £330,000.00 if the full extension period is adopted.

The new service will commence on the 1st October 2025

This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

II.1.5) Estimated total value

Value excluding VAT: 330 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS code:

UKK23

II.2.4) Description of the procurement

NHS Somerset Integrated Care board (ICB) is seeking to secure a Prime Provider who has the capability and capacity to deliver Covid Medicines Delivery Unit (CMDU) Services to People who are registered with a GP practice in Somerset or normally resident in Somerset who:

a) have been identified by NHSE or their consultant/specialist as high risk of an adverse Covid outcome

b) have Covid symptom onset and/or a positive lateral flow test

This service is for non-hospitalised adults who meet the criteria for assessment.

To assess and prescribe oral antiviral medications for the treatment of Covid, safely and effectively for patients eligible and suitable for this treatment.

Desired Outcomes:

• The patient has access to Covid medication within 5 days of symptom onset/positive lateral flow test

• Patients assessed overnight are expected to be assessed via a remote service the next day.

If for reasons of service sickness, a patient can be delayed for 24 hours. Anything further needs to be escalated to the ICB for agreement

The service will assess all patients in the community aged 18 years and over who are identified as being at high risk of an adverse outcome from Covid and have Covid symptoms and/or a positive lateral flow test. It is expected that these patients will have been provided with a letter by NHSE or have been identified as high risk by their specialist/consultant.

The service will assess the patient and where appropriate prescribe Covid medications. Where the patient does not fit the criteria for oral medication but may be eligible for second line intravenous medication, the service will make a referral to Somerset NHS Foundation Trust (Somerset FT) via Somerset Primary Link (SPL) for consideration and treatment if appropriate.

Referrals into the service are to be triaged on the day they are received. For those referrals received within 1 hour of the service closing time, the number of days since symptom onset should be ascertained. If clinically appropriate and the 5-day threshold will not be breached, the assessment of these patients may be delayed to the next opening day.

Assessments will be conducted remotely by telephone/video call. In instances when this default approach is not appropriate, online communication or another suitable method of communication will be utilised. To ensure an inclusive service, the service will make reasonable adjustments which includes for example (but not limited to) textphone, sign language, interpreter.

Patients are to be provided with advice on steps to take should they become more unwell, and "worsening advice" should also be given to those not eligible for any Covid medication. All patients should be provided with Covid infection control advice.

This service will be provided remotely.

It will operate for a minimum of 6-days per week throughout the year including morning and afternoon provision referred to as "core hours" in this specification, except for weeks where there is a normal UK national bank holiday (Good Friday, Easter Monday, May Day, Spring Bank Holiday, Summer Bank Holiday, Christmas Day, Boxing Day, New Year's Day). During the weeks when these bank holiday dates fall, the service may operate for a minimum of 5-days per week, but must not be closed for more than 3 consecutive days. Closure dates must interface with Community Pharmacy.

The contract term will be for 2 years with an optional extension of any period up to 1 year.

The contract value is £110,000.00 per annum giving a contract value of £220,000.00 for the initial contract period and £330,000.00 if the full extension period is adopted.

The new service will commence on the 1st October 2025

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 330 000.00  GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: Yes

Description of options:

There is an option to extend the contract up to 12 months after the 2 years.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

See procurement documentation for full details.

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

List and brief description of selection criteria:

See procurement documentation for full details.


III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 17/03/2025

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

IV.2.7) Conditions for opening of tenders

Date: 17/03/2025

Local time: 13:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.3) Additional information

There must be a link to where the procurement documents can be found (if not entered as part of this notice). This must include instructions on how to submit bids (which must be by electronic means) and what information should be included in the bid. It must set out the contract award criteria (including the relative importance of the key criteria) and how the contract award criteria will be assessed, including whether the assessment will be in stages."

Interested providers will be able to view this opportunity via the live opportunities list on the 'Health Family' e-procurement system, Atamis. Click on 'View our Live Opportunities' from the home page, available on the following link: https://health-family.force.com/s/Welcome.

Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the bid documentation (including questionnaires), you will need to click on 'Register interest' - this will take you to the log-in page.

If you are not already registered on the system, you will need to do so before gaining full access to the documentation and be able to submit a bid.

This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

VI.4) Procedures for review

VI.4.1) Review body

NHS Somerset Integrated Care Board

Yeovil

BA228HR

UK

VI.5) Date of dispatch of this notice

13/02/2025

Coding

Commodity categories

ID Title Parent category
85100000 Health services Health and social work services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
Ian.Weston3@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.